OR WAIT null SECS
January 21, 2022
The company is voluntarily recalling one batch of Semglee prefilled pens because of a potential missing label.
AstraZeneca's Tagrisso has been accepted for use as a monotherapy for the first-line treatment of adult patients with locally advanced or metastatic NSCLC with activating EGFR mutations in Scotland.
Air France KLM Martinair Cargo and Envirotainer are collaborating on more sustainable air transport of pharmaceuticals
PharmaLex Group has merged with MAP Group, broadening its market access expertise and extending its reach into the Italian marketplace.
Cyxone has appointed a European CDMO to scale-up and produce the active ingredient of its T20K drug candidate.
January 19, 2022
The company is voluntarily recalling one lot of Senna Syrup 8.8mg/5mL, unit-dose cups because of microbial contamination.
The agency discusses its response to COVID-19 and other milestones in its year-end review.
The agency’s COVID-19 task force says latest data shows use of COVID-19 mRNA vaccines during pregnancy is safe.
January 14, 2022
According to the company, Lumykras (Sotorasib) is the first targeted therapy approved in the European Union for patients with the KRAS G12C mutation.
The UK’s National Institute of Health and Care Excellence has recommended the use of Janssen’s Darzalex (daratumumab) in combination with Velcade (bortezomib), thalidomide and dexamethasone (DVTd) to treat adults with multiple myeloma.